Item
CAFFEINE ANYHYDROUS USP KOSHER CSPC (3093629 210 04M)
Food Ingredient
Locations
| Location name | Address |
|---|---|
| CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | NO. 36 FUQIANG WESTERN ROAD LUANCHENG COUNTY SHIJIAZHUANG CITY, HEBEI PROVINCE 0 CHN |
Documents
| Type | Location |
|---|---|
| Allergens | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Gluten | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| GMO | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Ingredient Regulatory Status Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| HACCP Plan (Item) | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| HACCP Process Flow Diagram | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Heavy Metals Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Irradiation Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Kosher | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Animal Testing Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Product Label Sample | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Lot Code Explanation | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Animal-Origin Materials Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Nutrition | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Pesticide Residue Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Phthalates Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Product Specification | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Residual Solvents Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Safety Data Sheet (SDS) | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Certificate of Analysis Sample | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Sewage Sludge Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Shelf Life and Storage Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Vegan / Vegetarian Status | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Prohibited Substances in Sport Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| BSE / TSE Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Proposition 65 Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Country of Origin | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Ethylene Oxide Statement | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Compliance Declaration - Food Contact Materials (Item) | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Halal | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Label Claims Substantiation | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| FSVP Assessment | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Natural Claims Substantiation | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Letter of Continuing Guarantee | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Organic | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Ingredient Declaration | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
| Suitability Requirements | CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI |
